Skip to main content
TLSA
NASDAQ Life Sciences

Tiziana Signs MOU to Test Foralumab Combo in RRMS

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.817
Mkt Cap
$98.811M
52W Low
$0.762
52W High
$2.35
52W Position info
7.3% above low
Off High info
65% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

TLSA is trading near its 52-week low of $0.762 (7.3% above the low).

Summary

Tiziana Life Sciences signed an MOU with KAIMRC and the Foundation for Neurologic Diseases to study intranasal foralumab combined with anti-CD20 therapy in RRMS patients who respond poorly to anti-CD20 alone. This expands foralumab's pipeline beyond na-SPMS into a defined clinical niche with unmet need. The company's na-SPMS Phase 2 readout remains expected in October, a near-term binary event. Prior studies showed neuroinflammation reduction, supporting the combination rationale. A formal trial initiation and positive efficacy signals would broaden the drug's addressable market and could attract partnerships or funding.

At the time of this announcement, TLSA was trading at $0.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $98.8M. The 52-week trading range was $0.76 to $2.35. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TLSA - Latest Insights

TLSA
Nov 05, 2026, 2:26 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.6249
Real-time Price: $0.6432 info
Change: +$0.0183 (+3%) info
Market Cap: $79.629M info
TLSA
Nov 02, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.890
Real-time Price: $0.6432 info
Change: -$0.2468 (-28%) info
Market Cap: $79.629M info
TLSA
Nov 02, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.8685
Real-time Price: $0.6432 info
Change: -$0.2253 (-26%) info
Market Cap: $79.629M info
TLSA
Oct 16, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.6432 info
Change: -$0.4068 (-39%) info
Market Cap: $79.629M info
TLSA
Oct 16, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.6432 info
Change: -$0.4268 (-40%) info
Market Cap: $79.629M info